Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Employing multi-omics technologies to identify ferroptosis-related molecular biomarkers, coupled with large-scale clinical trials, will aid in validating the efficacy of ferroptosis inhibitors and promote their clinical application
Manage Payer-Specific Compliance for You Every payer has its own rules
Proper refrigeration, light protection, and sterile handling are key to maximizing the benefits of your treatment
BP elevated
[DOI] [PMC free article] [PubMed] [Google Scholar] Choudhury Y, Toh YC, Xing J, Qu Y, Poh J, Li H, Tan HS, Kanesvaran R, Yu H, and Tan MH (2017) Patient-specific hepatocyte-like cells derived from induced pluripotent stem cells model pazopanib-mediated hepatotoxicity
US$ 22.42
US$ 21.59
US$ 29.70
